(Q44297147)

English

Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes (English)

1 reference

Europe PubMed Central

1 December 2017

Marie-Isabel Aguilar

5

object named as

Marie-Isabel Aguilar

1 reference

Europe PubMed Central

1 December 2017

author name string

Supundi Subasinghe

1

1 reference

Europe PubMed Central

1 December 2017

Sharon Unabia

2

1 reference

Europe PubMed Central

1 December 2017

Colin J Barrow

3

1 reference

Europe PubMed Central

1 December 2017

Su San Mok

4

1 reference

Europe PubMed Central

1 December 2017

David H Small

6

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

1 December 2017

Journal of Neurochemistry

1 reference

Europe PubMed Central

1 December 2017

84

1 reference

Europe PubMed Central

1 December 2017

471-479

1 reference

Europe PubMed Central

1 December 2017

3

1 reference

Europe PubMed Central

1 December 2017

Characterization of high-affinity binding between gangliosides and amyloid beta-protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cholesterol, A beta and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Isolation of rat hepatocyte plasma membranes. I. Presence of the three major domains

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cell cycle-specific effects of lovastatin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Profile of changes in lipid bilayer structure caused by beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Analysis of antimicrobial peptide interactions with hybrid bilayer membrane systems using surface plasmon resonance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Regulation of APP cleavage by alpha-, beta- and gamma-secretases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Amyloid and lipids in the pathology of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Alzheimer's disease and Abeta toxicity: from top to bottom

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

The structural role of cholesterol in biological membranes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Neuropeptides interact with glycolipid receptors: a surface plasmon resonance study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cerebral amyloid angiopathy. A critical review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Reduction in cholesterol and sialic acid content protects cells from the toxic effects of beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Cellular membrane composition defines A beta-lipid interactions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01552.X

21 January 2018

Identifiers

10.1046/J.1471-4159.2003.01552.X

1 reference

Europe PubMed Central

1 December 2017

release_hbx7spfusbfhrlas2m5hijufr4

1 reference

https://api.fatcat.wiki/v0/release/hbx7spfusbfhrlas2m5hijufr4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44297147&oldid=2109252960"